| Mariann Staph, LPN | |
|
2305 Wilmington Rd Ste 3, New Castle, PA 16105-1959 | |
| (724) 965-8355 | |
| Not Available |
| Full Name | Mariann Staph |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 2305 Wilmington Rd Ste 3, New Castle, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013790872 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | PN317658 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mariann Staph, LPN 1032 Butler Ave, New Castle, PA 16101-4247 Ph: (724) 510-5101 | Mariann Staph, LPN 2305 Wilmington Rd Ste 3, New Castle, PA 16105-1959 Ph: (724) 965-8355 |
News Archive
Liver transplant patients with hepatitis C virus (HCV) achieved significantly better long-term viral response when taking the immunosuppressive agent Cyclosporine along with interferon-ribavirin combination therapy. Cyclosporine also showed efficacy against Hepatitis C virus in vitro.
Alere, a global leader in rapid diagnostics, today doubled its commitment to the Organisation of African First Ladies Against HIV/AIDS in its efforts to reduce the impact of HIV/AIDS in Africa by eliminating mother-to-child transmission of HIV and increasing early infant diagnosis (EID).
AstraZeneca today announced that the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted regulatory submissions for review of the investigational drug vandetanib in the treatment of patients with advanced medullary thyroid cancer (MTC). The FDA also granted priority review status for the new drug application and set a Prescription Drug User Fee Act (PDUFA) action date of 7 January 2011.
Reports of a serious polio outbreak among children in Rogo, Kano State, have emerged. Kano is Nigeria's most populous northern state.
Italian scientists pioneering a new gene transfer treatment for the blood disorder β-thalassemia have successfully completed preclinical trials, claiming they can correct the lack of beta-globin (β-globin) in patients' blood cells which causes the disease. The research, published in EMBO Molecular Medicine, reveals how gene therapy may represent a safe alternative to current cures that are limited to a minority of patients.
› Verified 5 days ago
Diana Johnston, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2305 Wilmington Rd Ste 3, New Castle, PA 16105 Phone: 724-965-8355 | |
Rachael Leigh Williot, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 831 Harrison St, New Castle, PA 16101 Phone: 724-652-5144 | |
Melissa Schettler, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 831 Harrison St, New Castle, PA 16101 Phone: 724-662-5144 | |
Lonnie Jinks, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2305 Wilmington Rd Ste 3, New Castle, PA 16105 Phone: 724-965-8355 Fax: 877-456-7299 | |
Diana Stephens, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2305 Wilmington Rd Ste 3, New Castle, PA 16105 Phone: 724-965-8355 | |
Karen Sue Short, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 831 Harrison St, New Castle, PA 16101 Phone: 724-652-5144 |